• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

Short and Funny Sayings for a Happy Summer with Friends

May 9, 2025

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Friday, May 9
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    Trump Announces First Post-Tariff Trade Deal

    May 8, 2025

    Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

    May 7, 2025

    Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

    May 7, 2025

    Federal Reserve Holds Interest Rates Steady Despite Pressure From Trump

    May 7, 2025

    ‘Wait Them Out’: John Kennedy Tells Larry Kudlow One Lie He Suspects China’s Telling US

    May 7, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Business»Novo Nordisk, Lilly see insatiable demand for weight-loss drugs
Business

Novo Nordisk, Lilly see insatiable demand for weight-loss drugs

November 2, 2023No Comments4 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

[1/2]The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing Rights

Nov 2 (Reuters) – Novo Nordisk (NOVOb.CO) and Eli Lilly (LLY.N) both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years – limited only by their availability.

The two companies have been the primary beneficiaries of the global boom in obesity drugs, ballooning their market values and reshaping expectations not just in the healthcare industry, but also for sellers of sugary snacks, nutritional aids and packaged foods.

Sales of Wegovy and Ozempic for Novo and Lilly’s Mounjaro surpassed expectations in the most recent quarter reported on Thursday, and both companies flagged their inability to manufacture enough supply to keep up with skyrocketing demand.

That squeeze could worsen once Lilly’s Mounjaro, currently only approved for type 2 diabetes but being increasingly used “off-label” for weight loss, wins U.S. approval to treat obesity, likely by the end of the year.

Danish drugmaker Novo Nordisk, which overtook LVMH (LVMH.PA) as Europe’s most valuable listed company this year, posted record operating profit for the third quarter, with Wegovy sales reaching $1.36 billion, up 28% from the previous quarter.

“At this point, the market is supply driven and every vial of (these weight-loss drugs) is getting used,” said BMO analyst Evan Seigerman.

Novo expects double-digit sales growth in 2024 for Wegovy and Ozempic, which have the same active ingredient, semaglutide.

Indianapolis-based Lilly, now the world’s most valuable healthcare company worth $526 billion, reported Mounjaro sales of $1.41 billion, surpassing $1 billion in a quarter for the first time. It aims to double last year’s supply capacity by the end of 2023.

See also  Burger King Faces $15 Million Lawsuit Over ‘Open Air Drug Bazaar’: REPORT

“With all the investments we’re making and the production plans, the expected demand for (Mounjaro) will be quite significant. So we can be in a tight situation for some time,” said Anat Ashkenazi, Lilly’s chief financial officer, in an interview.

Novo in May limited the number of U.S. patients who can start treatment with Wegovy. “We’ll be supplying significantly more in 2024 compared to what we are in 2023,” Novo CFO Karsten Munk Knudsen said in an interview.

The success of these drugs and the publicity around them has driven a buying frenzy in both Novo and Lilly shares, which have risen 47% and 52%, respectively, in 2023.

Coming into Thursday, both companies sported price-to-earnings ratios that far surpass their peers. Novo’s P/E is now at 46.5, while Lilly’s is at a lofty 77. Most major drugmakers are between 10 and 20, according to LSEG data.

Shares of Novo rose 3% on Thursday while Lilly was up 4%.

The “number one question on investor’s minds is when will Wegovy supply growth resume? When will they open the gates to allow new patients to start?” said Nicholas Anderson, a portfolio manager at Thornburg Investment Management, which holds Novo Nordisk shares.

The success of the drugs has prompted investors to sell shares of healthcare companies that have profited from the obesity epidemic, because they treat diabetes, sleep apnea and other conditions that are exacerbated by excess weight. Several food and packaging companies have also said the drugs could have an effect on demand.

Johnson & Johnson (JNJ.N) last month reported that sales of its devices used for bariatric surgery took a hit as many obese patients turned to the weight-loss drugs instead.

See also  Australian casino group Star Entertainment to raise $481 million in equity

The iShares Medical Devices exchange-traded fund has lost 12% so far this year, while the Invesco Food and Beverage ETF is down 8.3%.

In early October, Walmart (WMT.N), the largest U.S. retailer, said the success of weight-loss drugs was driving a slight pullback in food consumption.

Analysts have cautioned that food companies could be hit in coming months as drugs like Wegovy and Mounjaro become more readily available.

Reporting By Jacob Gronholt-Pedersen, Bhanvi Satija, Patrick Wingrove and Maggie Fick; writing by David Gaffen; Editing by Bill Berkrot

: .

Acquire Licensing Rights, opens new tab

Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States. She has a postgraduate degree in International Journalism from City, University of London.

demand drugs insatiable Lilly Nordisk Novo weightloss
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

May 7, 2025

Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

May 7, 2025

Federal Reserve Holds Interest Rates Steady Despite Pressure From Trump

May 7, 2025
Add A Comment

Leave A Reply Cancel Reply

Top Posts

Asana stock soars 24% as software company cites improving path to profitability

March 9, 2023

“We knew it was going to be a grinding day”

March 12, 2023

Earthquakes Cause Chain Reactions For Public Health And Safety

September 13, 2023

UPDATE: Choir Director Tells Gateway Pundit After US Capitol Police Incident – “I Said, You’re Telling Me that a Group of Children Can’t Sing the National Anthem in their Own Capitol?” and She Said, “That’s Right” | The Gateway Pundit

June 2, 2023
Don't Miss

Short and Funny Sayings for a Happy Summer with Friends

Lifestyle May 9, 2025

I love the beach. Just looking at the calming sea to relax. Having fun in…

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,110)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,627)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

BIG MISTAKE! After Drubbing by Trump CNN Invites Rep. Byron Donalds on the Post-Debate Show for a Second Round of Public Humiliation (VIDEO) | The Gateway Pundit

May 11, 2023

Electric Car Manufacturers Remove AM Radios Claiming Safety Concerns

March 20, 2023

Blue Jays Demote Christian Pitcher Anthony Bass On Pride Night

June 10, 2023
Popular Posts

Short and Funny Sayings for a Happy Summer with Friends

May 9, 2025

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.